Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 8Insulin Resistance 2Hyperandrogenism 2Overweight 1Metabolic Syndrome 1Menstruation Disturbances 1Infertility 1

Interventions

Metformin 4Inositol 3drospirenone and ethinyl estradiol combination 2Progesterone 2Folic Acid 2Ethinyl Estradiol 2Cyproterone Acetate 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Time 1Thioctic Acid 1Sugars 1Spironolactone 1Sodium Salicylate 1Phlebotomy 1Lactalbumin 1Inulin 1Insulin 1Glycoprotein Hormones, alpha Subunit 1Flutamide 1Estrogens 1Estradiol 1Doxycycline 1Clomiphene 1Cardiovascular Physiological Phenomena 1Body Mass Index 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hyperandrogenism × drospirenone and ethinyl estradiol combination × Clear all
NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed
51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01511822 2012-01-19

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

AGUNCO Obstetrics and Gynecology Centre

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡